
FDA Approves Zurzuvae: Game-Changing Medication for Postpartum Depression
The U.S. Food and Drug Administration recently approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs …
FDA Approves Zurzuvae: Game-Changing Medication for Postpartum Depression Read More